CliniGA CRO

CliniGA CRO Blog

IND safety reporting: documenting reportability decisions

Automatically routing every serious adverse event through the same external reporting pathway can obscure useful safety information.

Cover image for: IND safety reporting: documenting reportability decisions
Photo: National Institute of Allergy and Infectious Diseases · License: Public domain · Cropped and resized.
Published
Updated
Sources checked

Automatically routing every serious adverse event through the same external reporting pathway can obscure useful safety information. A structured decision record makes medical assessment, evidence and the reason for the sponsor’s reportability decision visible to subsequent reviewers.

Separate decision variables

21 CFR 312.32 establishes reporting conditions for specified safety information, including serious unexpected suspected adverse reactions. Assess seriousness, expectedness and causality separately. An event being a protocol endpoint does not automatically close the safety evaluation or remove the need to consider evidence of causation.

Design the medical review record

A decision record can capture initial awareness, available clinical facts, the reference safety information used, causal reasoning and decision ownership. Route situations requiring assessment of accumulated data for medical review rather than forcing every issue into an isolated case assessment.

Check the reporting pathway

After the decision, clarify recipients, submission format and responsibility for follow-up information. A decision not to submit also needs supporting reasoning. Do not assume that the applicable reporting clock stops while missing information is sought from a site or another source.

  • Record seriousness, expectedness and causality separately.
  • Retain the reference version used in the decision.
  • Review follow-up information against the previous assessment.

Reassess with new evidence

Follow-up may change the assessment. Preserve the earlier decision while recording new evidence, revision date and subsequent action. Use a common event identifier across clinical and safety systems so reconciliation can distinguish a true disagreement from different versions of the same case.

Frequently asked questions

Does every SAE have the same external pathway?
No. Investigator reporting and sponsor regulatory reportability assessment are different steps.
Does missing information stop the reporting clock?
Do not assume so. Assess available information while managing follow-up and required reporting together.

Sources

  1. eCFR — 21 CFR 312.32
  2. FDA — ICH E2A Clinical Safety Data Management